The effects of 13-cis retinoic acid and interferon-α in chronic myelogenous leukemia cells in vivo in patients

Leukemia Research

Volumn 21, Issue 11-12, 1997, Pages 1087-1096

  Handa, Hiroshi ^a   Hegde, Upendra P ^a   Kotelnikov, Valery M ^a   Mundle, Suneel D ^a   Dong, Li Ming ^a   Burke, Paul ^a   Rose, Sheldon ^a   Hsu, Wei Tong ^a   Gaskin, Fred ^a   Raza, Azra ^a   Preisler, Harvey D ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

CML; Interferon; Retonic acid

Indexed keywords

ALPHA INTERFERON; CYTARABINE; CYTOKINE; HYDROXYUREA; ISOTRETINOIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW; CELL CYCLE S PHASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; ONCOGENE MYC; PRIORITY JOURNAL; PROTO ONCOGENE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BONE MARROW; FEMALE; HUMANS; INTERFERON-ALPHA; ISOTRETINOIN; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 0031455683     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00090-8     Document Type: Article

References (17)

1. Carella, A. E., Pollicardo, N., Pungolino, E., Raffo, M. R., Podesta, M., Ferreo, R., Pierluigi, D., Naibo, K. and Cogiu, A., Mobilization of cytogenetically normal blood progenitor cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia. Leukemia Lymphoma, 6, 1993, 9, 477.
2. Cunningham, I., Gee, T., Dowling, M., Chaganti, R., Bialey, R., Hopfan, S., Bowden, L., Turnbull, A., Knapper, W. and Clarkson, B., Results of treatment of Ph' + chronic myelogeneous leukemia with an intensive treatment regimen (L-5 protocol). Blood, 3, 1979, 53, 375.
3. Tura, S., A clinical trial of early splenectomy, hydroxyurea and cyclic cytosine arabinosyl, vincristine, and prednisone in chronic myeloid leukemia. Italian Cooperative Study Group on chronic myeloid leukemia. Semin. Hematol., 1975, 8, 121.
4. Mundle, S., Iftikhar, A., Shetty, V., Alvi, S., Dameron, S., Gregory, S., Marcus, B., Khan, S., Preisler, H. D. and Gopal, V., Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment. Leukemia Res., 3, 1994, 18, 149.
5. Preisler, H. D., Raza, A. and Baccarani, M., Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogeneous leukemia. Leukemia Lymphoma, 1, 1993, 11, 303.
6. Preisler, H. D., Gopal, V., Banavali, S. D., Finke, D. and Bokari, S. A. J., Multiparameter assessment of the cell cycle effects of bioactive and cytotoxic gents. Cancer Res., 1992, 52, 4090.
7. Preisler, H. D., Raza, A. and Larson, R. A., Alteration of the proliferative rate of acute myelogeneous leukemia cells in vivo in patients. Blood, 10, 1992, 80, 2600.
8. Bollag, W., Retinoids and interferon: a new promising combination. Br. J. Haematol., 1, 1991, 79, 87.
9. Toma, S., Monteghirfo, S., Tasso, P., Nicolo, G., Spadini, N., Palumbo, R. and Molina, F., Antiproliferative and synergistic effects of interferon alpha-2a, retinoids and their association in established human cancer cell lines. Cancer Lett., 2, 1994, 82, 209.
10. Kantarjian, H. M., Deisseroth, A., Kurzrock, R., Estrov, Z. and Talpaz, M., Chronic myelogeneous leukemia: a concise update. Blood, 3, 1993, 82, 691.
11. Hulette, B. C., Banavali, S. D., Finke, D. P., Gopal, V. and Preisler, H. D., Protooncogene expression in subpopulations of cells from leukemia patients. Cytometry, 6, 1992, 13, 653.
12. Raza, A., Maheshwari, Y. and Preisler, H. D., Differences in cell cycle characteristics amongst patients with acute non-lymphocytic leukemia. Blood, 6, 1987, 69, 1647.
13. Gopal, V., Hulette, B., Li, Y. Q., Kuvelkar, R., Raza, A., Larson, R., Goldberg, J., Tricot, G., Bennett, J. and Preisler, H. D., C-myc and C-myb expression in acute myelogeneous leukemia. Leukemia Res., 10, 1992, 16, 1003.
14. Lippman, S. M., Parkinson, D. R., Itri, L., Weber, R. S., Schantz, S. P., Ota, D. M., Schusterman, M. A., Krakoff, I. H., Gutterman, J. U. and Hong, W. K., 13 cis-retinoic acid and interferon-α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J. Natl. Cancer Inst., 4, 1992, 84, 218.
15. Lippman, S. M., Kavanagh, J. J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Holdener, E. E. and Krakoff, I. H., 13-cis retinoic acid and interferon-α-2a: highly active systematic therapy for squamous cell carcinoma of the cervix. J. Natl. Cancer Inst., 4, 1992, 84, 241.
16. Lippman, S. M., Glisson, B. S., Kavanagh, J. J., Lotan, R., Hong, W. K., Paredes-Espinoza, M., Hittelman, W. N., Holdener, E. E. and Krakoff, I. H., Retinoic acid and interferon combination studies in human cancer. Eur. J. Cancer, Suppl. 5, 1993, 29a, S9.
17. Lippman, S. M., Kavanagh, J. J., Paredes-Espinoza, M., Delagadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Massimmini, G., Holdener, E. E. and Krakoff, I. H., 13-cis retinoic acid plus interferon-α 2a in locally advanced squamous cell carcinoma of the cervix. J. Natl. Cancer. Inst., 6, 1993, 85, 499.